Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

Haematologica, Vol 92, Issue 8, 1091-1098 doi:10.3324/haematol.10702
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldin-Lang, P.
Right arrow Articles by Rauch, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldin-Lang, P.
Right arrow Articles by Rauch, U.

Disorders of Hemostasis

Effect of ionizing radiation on cellular procoagulability and co-ordinated gene alterations

Petra Goldin-Lang, Klaus Pels, Quoc-Viet Tran, Bjoern Szotowski, Frank Wittchen, Silvio Antoniak, Tobias Willich, Henning Witt, Michael Hummel, Dido Lenze, Wolfgang Poller, Heinz-Peter Schultheiss, Ursula Rauch

From the Department of Cardiology and Pneumology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany (PG-L, KP, Q-VT, BS, FW, SA, TW, WP, H-PS, UR); Center for Cardiovascular Research, Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany (HW); Department of Pathology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany (MH, DL)

Correspondence: Ursula Rauch, MD, Medical Clinic II, Charité-Universitätsmedizin Berlin Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany. E-mail: ursula.rauch{at}charite.de


   ABSTRACT
TOP
 ABSTRACT
Design and Methods
 Results
 Discussion
 References
 
Background and Objectives: Ionizing radiation (IR) is associated with thrombotic vascular occlusion predicting a poor clinical outcome. Our study examined whether IR induced tissue factor (TF) expression and procoagulability. We further investigated coordinated gene alterations associated with TF upregulation in the myelomonocytic leukemia THP-1 cells.

Design and Methods: TF expression was determined by quantitative Reverse Transcriptase (TaqMan®) PCR, TF ELISA and TF activity by a two stage chromogenic assay in the time course of days 1, 3, 7, 10, and 17 post IR. To detect IR-induced alterations in gene expression, Affymetrix HG U133 Plus 2.0 microarrays were used.

Results: IR induced a significant increase in TF/GAPDH mRNA ratios and cellular TF protein on days 3 and 7 post IR (20 Gy [p≤0.01] and 40 Gy [p≤0.01 vs. control]), suggesting a late and persistent induction of TF. An increase in cellular TF activity was already found 1 day post IR (20 Gy and 40 Gy [p≥0.001] vs. control respectively), suggesting IR immediately alters the cellular thrombogenicity. TF upregulation post IR was confirmed in PBMNCs. Gene expression profiling showed IR increased the expression of inflammatory and apoptosis-related pathways known to be involved in the regulation of TF expression.

Interpretation and Conclusions: TF upregulation together with inflammation and apoptosis may increase the thrombogenicity of tissues. The demonstrated upregulation of TF might play a pivotal role in radiation associated thrombosis.

Key words: gene expression profiles, ionizing radiation, myelomonocytic cell line THP-1, procoagulability, tissue factor.

Ionizing radiation (IR) is associated with an increased risk of thrombotic occlusion of vessels and organ fibrosis.1 Thrombotic events have been described as a major complication after IR.2 Cells surviving acute genotoxic stress post IR have been shown to display delayed responses that can result in persistent effects such as apoptosis and late thrombosis.3,4 Over-expression and increased activity5 of tissue factor (TF) have been shown to be involved in radiation-induced changes.6 Furthermore, cultures of human arterial endothelial cells expressed TF mRNA after irradiation in combination with mechanical denudation.7

Alterations in transcriptional factor activity may contribute to the increased thrombogenicity present post IR.1 Sreekumar et al.8 found TF protein to be upregulated in response to radiation treatment as shown by application of microarrays in LoVo colon carcinoma cells. TF, the initiator of the extrinsic coagulation system, induces thrombus formation by activation of Factor VII resulting in activation of Factors IX and X. TF is widely thought to play a leading role in thrombus formation during thrombotic disorders.9–13 Besides its role in hemostasis,13,14 upregulation of TF expression appears to be characteristic of tumor tissue. There, TF is expressed in malignant cells as well as in tumor-infiltrating macrophages and endothelial cells.15,16,17 The procoagulant activity of TF appears to play an important role in the development of disseminated intravascular disease (DIC).18 It has been shown that platelet activation and fibrin deposition is an essential part of TF-dependent metastasis.19 In addition, blood clotting abnormalities are detected in up to 90% of patients with metastatic disease, and thrombosis represents the most frequent cause of cancer mortality.20,21

Pathologic activation of the coagulation cascades by aberrant expression of TF on the surface of monocytes has been implicated in life-threatening thrombosis.22 TF is expressed on the surface of human leukocytes and leukemic myelomonocytic cells23,24 where it has been reported to increase cellular thrombogenicity. In this study, THP-1 cells were used as a model because of their cytologic, histochemical, and functional properties which resemble human monocytes.

In response to IR, monocytes have been reported to produce inflammatory cytokines such as TNF-{alpha}. NF{kappa}B, one of the main mediators of cellular responses involved in inflammation, apoptosis and regulation of TF expression, was documented to be activated by IR through a cascade requiring endogenous TNF-{alpha} production. 25

The aim of our study was to clarify whether IR induces the expression of procoagulant proteins such as TF in the THP-1 model over a time period of 17 days. In a second step, we examined coordinated gene alterations associated with IR-induced thrombogenicity and increased TF procoagulability on day 7 post IR.


   Design and Methods
TOP
 ABSTRACT
 Design and Methods
Results
 Discussion
 References
 
Human myelomonocytic leukemia cell line
The human monocytic cell line THP-1 has been purchased from LGC Promochem (Wesel, Germany). Cells were cultured in RPMI 1640 (GIBCO, Karlsruhe, Germany) supplemented with 10% Fetal Calf Serum (FCS) (GIBCO, Karlsruhe, Germany), 1mM L-glutamine (GIBCO, Karlsruhe, Germany), and 1% penicillin/streptomycin (GIBCO, Karlsruhe, Germany). They were tested and found to be mycoplasma and endotoxin free. Cell viability was assessed by trypan blue dye exclusion prior to all treatments.

Isolation of human peripheral blood mononuclear cells (PBMNCs) and human PBMNC culture
Human mononuclear cells were separated from blood samples as follows: 18 mL of EDTA treated human peripheral blood was diluted (1:2) in warm (37°C) phosphate-buffered saline (PBS, without Ca2+ and Mg2+ ) and purified by the Ficoll-Paque Plus. Then 7 mL of Ficoll-Paque were overlayed with 7 mL of the PBS-blood mixture and centrifuged (610xg, 25 mins., room temperature, without brake). The cell layer over the Ficoll-Paque was collected and washed two times in 10 mL PBS and centrifuged (610xg, 10 mins., room temperature). After the last wash, the cell pellet was resuspended in 500 µL RPMI 1640 supplemented with 10% Fetal Calf Serum (FCS), 1mM L-glutamine, and 1% penicillin/streptomycin. It was tested and found to be mycoplasma and endotoxin free. Cell viability was assessed by trypan blue dye exclusion prior to all treatments. For downstream applications, cells were counted in a hematocytometer (MICROS®60-OT System, Axonlab, Stuttgart).

Irradiation of THP-1 cells
THP-1 cells (106/mL) were irradiated with a single IR dose of either 20 or 40 Gray. IR was generated by a linear accelerator (Varian Clinac 600 CD) with a maximum photon energy of 6 MeV. Cell cultures were irradiated in a water-equivalent-environment by a 25x25 cm3 photon field. With this set-up, the dose homogeneity in the cell culture media is in a range of 100–105%. Following irradiation, cells were maintained in growth medium and afterwards subjected to further analysis. To evaluate the effect of the NF{kappa}B-pathway, inhibition experiments with BAY 11-7082 were performed with 4x105 THP-1 cells/mL. These were incubated 1h pre IR and daily up to 3 days post IR with 5 µM BAY 11-7082. Furthermore, THP-1 cells pre and post IR were subjected to RNA extraction and QRTPCR analysis.

Tissue factor ELISA
To quantify the total TF protein content in irradiated and control cells, THP-1 cells were subjected to ELISA according to the manufacturer’s instructions (Imubind Tissue Factor ELISA Kit, American Diagnostica, Pfungstadt, Germany).

Two stage chromogenic tissue factor activity assay
Measurement of TF activity was performed as previously described.14 Briefly, THP-1 cells were washed twice with phosphate buffered saline (PBS), incubated in HEPES buffer containing 0.1 M n-octyl-ß-D-glycopyranosid. After addition of Factor VIIa, Factor X and Ca2+ TF-dependent Factor Xa generation was measured at 405 nm using a chromogenic substrate for Factor Xa. TF activity units were assessed by a standard curve. The standard curve is constructed by plotting the mean slope absorbance value measured for each lipidated TF standard against its corresponding concentration [pg/mL] according to the manufacturer’s Actichrome® TF instruction sheet (American Diagnostica, Pfungstadt, Germany). The activity (generation of Factor Xa) exhibited by 1 pg of lipidated TF corresponds to 1 arbitrary TF-activity unit.

RNA extraction, reverse transcription
Total RNA of THP-1 cells or PBMNCs (106) was isolated by RNeasy Mini Kit including Qiashredder columns (Qiagen, Hilden, Germany). DNase I (Fermentas, St. Leon-Rot, Germany) digested, reverse transcription of RNA was performed with a First strand cDNA synthesis kit for RTPCR (AMV; Roche Applied Sciences) according to manufacturer’s instructions.

Quantitative real-time PCR (QRTPCR)
PCR conditions for the TaqMan® (ABI Prism7000 Sequence Detection System, Applied Biosystems, Darmstadt, Germany) are summarized in Table 1. Primers and probes were purchased from TIB Molbiol (Berlin, Germany). Data were analyzed using SDS 7000 software.


View this table:
[in this window]
[in a new window]
[Download PPT slide]
  		Table 1 A Primer and Probe Sequences, conditions and performance (50°C, 2min; 95°C, 10min; 40 cycles 95°C, 15s, 60°C, 1min) of quantitative real-time RT-PCR (QRTPCR) and conventional RT-PCR (cDNA standards for real time RT-PCR).

Table 1B Primers for QRTPCR analysis of expression levels of selected genes of IR exposed THP-1 cells.

 
GeneChip oligonucleotide microarrays target preparation
GeneChips (HG U133 Plus 2.0) were purchased from Affymetrix (Santa Clara, CA, USA). Target preparation and microarray processing were carried out according to the manufacturer’s recommendations. Briefly, 3 µg of total RNA was used to prepare double-stranded cDNA. Biotinylated cRNA was synthesized with an RNA transcript labeling kit and 20 µg of the cRNA product was chemically fragmented to approximately 50–200 nucleotides. Quality of RNA was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies GmbH, Waldbronn, Germany). The target for hybridization was prepared by combining 20 µg of fragmented cRNA and was hybridized to an Affymetrix HG U133 Plus 2.0 chip. Chips were washed and stained using the EukGE-WS2v5 protocol on an Affymetrix fluidics 450 station. The stain included streptavidin-phycoerythrin (10 µg/mL) and biotinylated goat anti-streptavidin (3 µg/mL). Fluorescence intensities were captured with an argonion laser confocal scanner.

Analysis of GeneChip data
Scanned output files were analyzed with GeneChip Operating Software 1.2 (GCOS; Affymetrix, Santa Clara, CA, USA). Fluorescence intensity was measured for each chip and normalized to the average fluorescence intensity for the entire chip. The normalized data set from three independent replicates (day 7 post IR; untreated controls versus irradiated THP-1 cells with a 20 Gy dose) was used for the Significance Analysis of Microarrays (SAM).26 The SAM statistic identifies significant changes in gene expression by performing a set of gene-specific t-tests. A score is calculated for each gene on the basis of changes in its expression relative to the standard of repeated measurements for that gene. Genes with scores greater than a threshold {Delta} are defined as significantly deregulated. A false discovery rate can be estimated from random permutations of all measurements. A cut-off of 1.8-fold expression (q-value ≤5%, only for TF gene: q-value >5%) was set to identify genes whose expression was significantly differentially regulated.

Statistical analysis
Data analysis was performed using SPSS 12.0. The Kolmogorov-Smirnov-Test was performed to test data distribution. Values are presented as mean ± standard error of mean (SEM) or median and interquartile range for non-parametric data. For parametric data, statistical significance of differences between groups was determined by applying the unpaired Student t-test or one-way analysis of variance (ANOVA) for multiple comparisons. The Mann-Whitney U-test was performed for non-parametric data: p<0.05 was considered significant. All experiments were performed at least five times.


   Results
TOP
 ABSTRACT
 Design and Methods
 Results
Discussion
 References
 
IR-induced upregulation of TF mRNA, protein and procoagulability in human monocytic cells
QRTPCR was performed on irradiated and non-irradiated THP-1 cells to investigate the effect of IR on TF expression. IR led to an increased mRNA expression of TF in irradiated THP-1 cells (Figure 1). On day 3 post IR (control vs. 20 Gy [p≤0.05] and vs. 40 Gy [p≤0.01]) and on day 7 post IR, TF/GAPDH mRNA ratios gave the highest mRNA expression levels (control vs. 20 Gy [p≤0.01] and vs. 40 Gy [p≤0.01], repectively) indicating a late induction of TF. PBMNCs were isolated from human peripheral blood to analyze the TF mRNA expression of mononuclear cells compared with the THP-1 cell model. A significant increase in TF/GAPDH mRNA ratios was found 1 day post IR (0.00041±0.00006 vs. 0.0022±0.0006, baseline vs. 20 Gy, p=0.008) and 3 days post IR of PBMNCs (0.00041±0.00006 vs. 0.006±0.002, baseline vs. 20 Gy, p=0.0016).


Figure 10921091
View larger version (11K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1. TF mRNA expression in THP-1 cells pre and 1, 3, 7 days post ionizing radiation (IR) with 0, 20 and 40 Gy. Upregulated TF mRNA 3 days post IR with doses of 20 and 40 Gy *p ≤0.05 {dagger}p ≤0.01 vs. control; {ddagger}p≤0.001 vs. control.

 
To analyze the NF{kappa}B-pathway related TF expression post IR, we performed mRNA expression studies by using the NF{kappa}B inhibitor BAY 11-7082. This inhibits I{kappa}B{alpha} phosphorylation. An inhibitor concentration of 5 µM had almost no effect on the growth of THP-1 cells. A significant inhibition of TF mRNA expression in irradiated cells pretreated with BAY 11-7082 was seen 3 days post IR compared to irradiated cells cultured without NF{kappa}B inhibitor (ratio HTF/HGAPDH 0.010±0.001 vs. 0.066±0.018; p≤0.0001). At day 3, when THP-1 cells were pretreated with NF{kappa}B inhibitor without application of IR, the TF mRNA expression of the NF{kappa}B inhibitor-pretreated cells was significantly downregulated compared to untreated control cells (ratio HTF/HGAPDH 0.009±0.001 vs. 0.012±0.001; p≥0.05). However, the application of IR without pretreatment with BAY11-7082 was associated with an increased TF mRNA expression compared to non-irradiated and untreated control cells 3 days post IR (ratio HTF/HGAPDH 0.066±0.018 vs. 0.012±0.001; p≤0.001). To confirm the data obtained on mRNA level, IR-induced expression of TF protein in THP-1 cells was quantified by ELISA recognizing human TF. A significant increase in cellular TF protein became prominent 3 days post IR with 20 Gy and with 40 Gy and persisted throughout the period of study (Figure 2A). A significant increase in cellular TF activity was already found 1 day post IR with 20 Gy and with 40 Gy, indicating IR alters cellular thrombogenicity (Figure 2B). A 12-fold increase was seen 7 days post IR with a dose of 20 Gy (Figure 2B, p≤0.001) and 40 Gy (p≤0.001) compared with untreated THP-1 control cells. Increased cellular prothrombogenicity was persistently measurable throughout the period of study (day 0-day 17) (Figure 2B).


Figure 20921091
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2. A. TF protein expression pre and 1, 3, 7, 10 and 17 days post ionizing radiation (IR) with 0, 20 and 40 Gy. Ionizing radiation-induced TF protein synthesis of THP-1 monocytic cells 3 days post IR. *p≤0.05; {dagger}p≤0.01 vs. control. B. TF associated procoagulant activity pre and 1, 3, 7, 10 and 17 days post IR. TF procoagulant activity increased 1 day post IR with doses of 0, 20 and 40 Gy. *p≤0.05; {dagger}p≤0.01; {ddagger}p≤0.001 vs. control.

 
Microarray analysis post IR: altered transcriptional Tissue Factor and gene expression profiles
Genechip microarray analysis was performed to clarify possible mechanisms underlying the increased expression of TF in THP-1 cells post IR.

The data discussed in this publication have been deposited in NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series access number GSE4110. We found a panel of candidate genes to be upregulated on day 3 and day 7 post IR. We performed only one pair of microarray analysis with day 3 post IR and the untreated control. On day 3 post IR, a generally weaker expression pattern of differentially expressed genes in irradiated THP-1 cells was detected. Therefore, 3 further replicate pairs (treated vs. untreated state) were chosen for the SAM statistics (Table 2). The number of genes with elevated expression increased in relation to an increased duration of culture time post IR. All detected 422 gene transcripts with known functions and significant upregulation (>1.8-fold, q≤5%) on day 7 post IR compared to non-irradiated controls are available in the online supplement. Altered transcription patterns post IR revealed genes belonging to the following groups: inflammation/cell defense, cell cycle arrest/apoptosis, regulation of transcription, nucleic acid metabolism, protein modification, cell structure/motility, and signaling/communication (Table 2).


View this table:
[in this window]
[in a new window]
[Download PPT slide]
  		Table 2. Differentially expressed genes in irradiated THP-1 cells. Data from individual samples for genes arranged in functional groupings are shown. K1-4: non-irradiated controls (replicates 1–4); day3IR, day7IR1-3: irradiated THP-1 cells (20 Gy); day3,7 post IR.

 
IR-responsive gene expression involved in regulation of cell thrombogenicity
We focussed on genes involved in inflammatory and apoptotic pathways which are known to be linked to changes in cellular thrombogenicity (Table 3). To validate upregulation of these candidate transcripts, SYBR Green QRTPCR was performed as well as the microarrays (Table 3).


View this table:
[in this window]
[in a new window]
[Download PPT slide]
  		Table 3. Comparison of relative expression levels measured by microarray analysis and by SYBR Green QRTPCR for selected genes.

 
The group IV phospholipase A2 (group IVC, cytosolic, Ca2+-independent; PLA2G4C) gene encodes for an enzyme important in membrane remodelling, activation and symmetry of lipid membrane, which is involved in cell thrombogenicity. QRTPCR confirmed a 4.1-fold upregulation of the group IV phospholipase A2 gene. QRTPCR also confirmed upregulation of cathepsin D (CTSD), an inducer of apoptosis in monocytes (Table 3).

Since TF is upregulated in monocytes under inflammatory conditions, especially by stimulation with TNF-{alpha}, we further verified the upregulation of TNFRSF10B (TRAIL R2/APO2LR/Killer/DR5). This is a gene for TNFrelated apoptosis-inducing ligand receptor 2 belonging to the cell signaling/communication group, known to be caspase-dependent and associated with apoptotic pathways (Table 3). QRTPCR showed IR clearly increased production of TNF (ligand) superfamily, member 13B (TNFSF13B) gene, a TNF-and APOL-related leukocyte expressed ligand 1, which is a TNF homolog activating the NF{kappa}B-, the JNK pathway and inducing apoptosis (Table 3). IFN-{alpha} inducible protein 27 (IFI27) gene was also seen to be highly upregulated post IR (Table 3).

We found three genes (TNFRSF10B, TNFSF13B and IFN-{alpha}inducible protein 27) whose regulation according to QRTPCR was considerably greater. This was also true of the TF gene, which was 1.8-fold (q-value > 5%) upregulated in the microarray experiment compared to a 3-fold upregulation measured by SYBR Green QRTPCR.


   Discussion
TOP
 ABSTRACT
 Design and Methods
 Results
 Discussion
References
 
In the present study IR was found to induce a persistent upregulation of TF on mRNA and protein level as well as TF procoagulant activity. Gene expression profiling showed IR also upregulated inflammatory and apoptosis-related pathways. TF activity was already upregulated on day 1 post IR, while increased TF protein and mRNA expression were found on day 3 in PBMNCs and in THP-1 cells. Although in many tumor cells all functional TF molecules are localized on the outer cell membrane, the procoagulant activity on the intact cell surface is largely dormant and can be enhanced by cell injury or damage.27 Bach et al.28 described cellular TF activity to be encrypted. TF may be deencrypted in several ways, for example by non-ionic detergents or calcium ionophores, thus leading to an increased TF activity without increasing TF mRNA or antigen expression. IR-induced activation of constitutively expressed TF on THP-1 cells may account for the early increase in procoagulant activity which was measurable before upregulated TF mRNA levels were found. As far as the extent of TF upregulation is concerned, a correlation was seen between the fold changes in normalized intensities as determined by microarrays and by QRTPCR analysis (Table 3). However, the magnitude of gene upregulation measured by SYBR Green QRTPCR was considerably higher in some of the candidate genes (Table 3). Compared to QRTPCR, the probeset for the TF gene on the microarray was not as sufficient for hybridization with cRNA of monocytic THP-1 cells potentially leading to weak signal intensities and lower ratio. Expression levels detected by QRTPCR were generally stronger than those obtained by the cDNA microarray. This fact may explain the observed differences in gene expression levels as presented here (Table 3). To widen out knowledge of the mechanisms and pathways involved in the delayed response to irradiation, gene expression patterns in irradiated and non-irradiated THP-1 cells were compared. We found an upregulation of a phospholipase A2 (PLA2) gene. This is involved in the assembly of membranes with coordinate synthesis, catabolism, and transport of phospholipids. In whole blood, activation of transcription factors is mediated through the phospholipase A2 pathway. At the surface of viable cells, the transmembrane phospholipid distribution and its regulation may be important for the expression of the catalytic activity of the complex of TF and activated Factor VII.29 Furthermore, phosphatidylserine supports the activity of the cell surface-complex of TF/FVIIa. Recent studies have shown that phosphatidylserine exposure is one of the earliest manifestations of apoptosis, and that it precedes loss of membrane integrity.30 Other cell death markers such as cathepsin D (CTSD) were also found to be increased post IR.

Several transcripts for interferon-inducible proteins along with those for IFN-{alpha}(IFN-{alpha}inducible protein 27; IFI27) and IFN-{gamma} showed elevated expression levels on day 3 and on day 7 post IR. IFN-{alpha} was reported to increase TNF-{alpha} induced apoptosis and, therefore, monocytes have been shown to rapidly undergo apoptosis in cultures. By contrast, endogenously produced TNF-{alpha} after {gamma}-irradiation was reported to result in enhanced monocyte survival by reducing induction of apoptosis.31 Many downstream targets of interferon were gradually induced following IR treatment. It is known that interferon operates through the JAK-STAT pathway in response to viral infections to mediate transcriptional changes in target genes. This results in antiproliferative effects, involved in suppressing viral replication. In case of IR stress, interferon activity may promote the same effects to prevent propagation of DNA damage.32 TNFRSF10B (TRAILR2) was found to be upregulated post IR. This TNF-{alpha} receptor is a potential activator of the NF{kappa}B pathway. 33 It is known that increased expression of the TF gene resulting in increased procoagulability is regulated via NF{kappa}B by various transcription factors, including NF{kappa}B/Rel proteins and Egr-1.34 Hachiya and co-workers25 ahowed that irradiation increased the NF{kappa}B binding activity and increased the production of TNF-{alpha} in THP-1 cells. Endogenous production of TNF-{alpha} is known to be required for NF{kappa}B activation post IR.35 Treatment of these cells with anti-TNF-{alpha} antibodies blocked the activation of NF{kappa}B induced by irradiation and exogenously added TNF-{alpha} stimulated NF{kappa}B activation. This is in line with the inhibition of TF mRNA expression in THP-1 cells using the NF{kappa}B pathway inhibitor BAY 11-7082 as shown here.

In conclusion, irradiation of human monocytic cells induced the upregulation of TF expression and procoagulant activity. The findings on upregulated TF mRNA expression in PBMNCs post IR are in line with our data obtained from irradiated THP-1 cells. We conclude that the THP-1 cells are a suitable model for studying the effect of various agonists on TF expression levels in human mononuclear cells. The demonstrated upregulation of TF and other regulatory pathways might play a pivotal role in radiation associated thrombosis and further studies are warranted to investigate this hypothesis.


   Acknowledgments
 
we thank Peter Rosenthal for his help in the radiation experiments and Franziska Bleis for her technical assistance


   Footnotes
 
Funding: Deutsche Forschungsgemeinschaft RA-799/3-1 (U. Rauch, K. Pels, P. Goldin-Lang), Sonderforschungsbereich Transregio 19 "Inflammatorische Kardiomyopathie-Molekulare Pathogenese und Therapie" Teilprojekt A3 (S. Antoniak), and DFG-Graduiertenkolleg 865 (B. Szotowski).

Authors’ Contributions

PG-L: writing the manuscript, interpretation of data, radiation experiments, TF TaqMan® PCR, microarray experiments; KP: contributed equally to the 1 st author’s work; Q-VT: radiation experiments, TF ELISA, TF activity assay; BS: critical revision of the manuscript and interpretation of data, discussion; FW: SAM statistics of microarray experiments; SA: validation experiments (SYBR Green TaqMan® PCR); TW: statistical analyses of TF mRNA-, TF ELISA-, and TF activity data; HW: critical revising microarray data and SAM statistics, online submission of microarray data into GEO; MH: providing of the Affymetrix working station, support in microarray experiments; DL: providing of the Affymetrix working station, support in microarray experiments; WP: critical revision of the manuscript, discussion, partly writing the manuscript, final approval of the manuscript; H-PS: critical revision of the manuscript, partly writing the manuscript, final approval of the manuscript; UR: main study concept, methods and design, critical revision and interpretation of data, partly writing the manuscript, final approval of the manuscript.

Conflict of Interest

The authors reported no potential conflicts of interest.

Received for publication August 25, 2006. Accepted for publication May 16, 2007.


   References
TOP
 ABSTRACT
 Design and Methods
 Results
 Discussion
 References
 

  1. Snyder AR, Morgan WF. Gene expression profiling after irradiation: Clues to understanding acute and persistent responses? Cancer and Metastasis Reviews 2004;23:259-68.[CrossRef][ISI][Medline]
  2. Saleem MA, Aronov WS, Ravipati G, Moorthy CR, Singh S, Agarwal N, Monsen CE, Pucillo AL. Intracoronary brachytherapy for treatment of in-stent restenosis. Cardiol Rev 2005;13:139-41.[CrossRef][Medline]
  3. Jamali M, Trott KR. Persistent increase in the rates of apoptosis and dicentric chromosomes in surviving V79 cells after X-irradiation. Int J Radiat Biol 1996;70:705-9.[CrossRef][ISI][Medline]
  4. Finkelstein A, Hausleiter J, Doherty TM, Takizawa K, Bergman J, Liu M, et al. Intracoronary b-irradiation enhances balloon-injury-induced tissue factor expression in the porcine injury model. Int J Cardiovasc Intervent 2004;6:20-7.[Medline]
  5. Verheij M, Dewit LGH, van Mourik JA. The effect of ionizing radiation on endothelial tissue factor activity and its cellular localization. Thromb Haemost 1995;73:894-5.[ISI][Medline]
  6. Van der Meeren A, Vandamme M, Squiban C, Gaugler M-H, Mouthon M-A. Inflammatory reaction and changes in expression of coagulation proteins on lung endothelial cells after total-body irradiation in mice. Radiat Res 2003;160:637-46.[CrossRef][ISI][Medline]
  7. Wondergem J, Wedekind LE, Bart CI, Chin A, van der LA, Beekhuizen H. Irradiation of mechanically-injured human arterial endothelial cells leads to increased gene expression and secretion of inflammatory and growth promoting cytokines. Atherosclerosis 2004;175:59-67.[CrossRef][ISI][Medline]
  8. Sreekumar A, Nyati MK, Varambally S, Barrette TR, Ghosh D, Lawrence TS, Chinnaiyan AM. Profiling cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 2001;61:7585-93.[Abstract/Free Full Text]
  9. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999;96:2311-5.[Abstract/Free Full Text]
  10. Rauch U, Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000;7:273-7.[CrossRef][ISI][Medline]
  11. Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000;10:139-43.[CrossRef][ISI][Medline]
  12. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000;96:170-5.[Abstract/Free Full Text]
  13. Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 2001;134:224-38.[Abstract/Free Full Text]
  14. Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005;96:170-5.
  15. Szotowski B, Goldin-Lang P, Antoniak S, Bogdanov VY, Pathirana D, Pauschinger M, et al. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol 2005;45:1081-9.[Abstract/Free Full Text]
  16. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003;9:458-62.[CrossRef][ISI][Medline]
  17. Rauch U, Antoniak S, Boots M, Schulze K, Goldin-Lang P, Stein H, et al. Association of tissue-factor upregulation in squamous-cell carcinoma of the lung with increased tissue factor in circulating blood. Lancet Oncol 2005;6:254.[CrossRef][ISI][Medline]
  18. Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:605-17.[CrossRef][ISI][Medline]
  19. Fernandez PM, Patierno SR, Rickles FR. Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemostas 2004;30:31-43.[ISI][Medline]
  20. DeCicco M. The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol/Hematol 2004;50:187-96.[Medline]
  21. Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol 2002;3:27-34.[CrossRef][ISI][Medline]
  22. Linenberger ML, Wittkowsky AK. Thromboembolic complications of malignancy. Part 1. Risk Oncol (Williston Park) 2005;19:853-61.
  23. Niemetz J, Fani K. Thrombogenic activity of leukocytes. Blood 1973;42:47-59.[Abstract/Free Full Text]
  24. Garg SK, Niemetz J. Tissue factor activity of normal and leukemic cells. Blood 1973;42:729-35.[Abstract/Free Full Text]
  25. Hachiya M, Takada M, Sekikawa K, Akashi M. Endogenous production of TNF-{alpha} ia a potent trigger of NF{kappa}B activation by irradiation in human monocytic cells THP-1. Cytokine 2004;25:147-54.[CrossRef][ISI][Medline]
  26. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionising radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.[Abstract/Free Full Text]
  27. Rao LV. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992;11:249-66.[CrossRef][ISI][Medline]
  28. Bach RR. Tissue Factor Encryption. Arterioscler Thromb Vasc Biol 2006;26:456-61.[Abstract/Free Full Text]
  29. Osterud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul Fibrinolysis 1998;9 Suppl_1: 9-14.
  30. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, VanSchie RCAA, Laface DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545.[Abstract/Free Full Text]
  31. Estaquier J, Ameisen C. A Role for T-Helper Type-1 and Type-2 cytokines in the regulation of human monocyte apoptosis. Blood 1997;90:1618-25.[Abstract/Free Full Text]
  32. Jen K-Y, Cheung VG. Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Research 2003;13:2092-100.[Abstract/Free Full Text]
  33. Weingartner M, Siegmund D, Schlecht U, Fotin-Mleczek M, Scheurich P, Wajant H. Endogenous membrane tumor necrosis factor (TNF) is a potent amplifier of TNF receptor 1-mediated apoptosis. J Biol Chem 2002;277:35853-9.[Abstract/Free Full Text]
  34. Guha M, O’Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, et al. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor {alpha} expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 2001;98:1429-39.[Abstract/Free Full Text]
  35. Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest 1991;87:1794-7.[ISI][Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldin-Lang, P.
Right arrow Articles by Rauch, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldin-Lang, P.
Right arrow Articles by Rauch, U.

HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS